Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Immunotherapy
Immunotherapy
,
Oncology
Adoptive T-Cell Therapy: Ready for Prime Time
Chase Doyle
Read More
Immunotherapy
,
Oncology
Maximizing the Potential of Immunotherapy the Focus of Cancer Moonshot 2020
Wayne Kuznar
Read More
Immunotherapy
,
Oncology
Immunotherapies Steal the Show at ASCO 2015
Chase Doyle
Read More
Immunotherapy
,
Oncology
Combination Immunotherapy Superior to Monotherapy in Patients with Melanoma
Chase Doyle
Read More
1
2
Page 2 of 2
Results 11 - 14 of 14